Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.
about
Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococciCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciSystematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremiaClinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of AmericaA pilot study of the efficacy and safety of empiric daptomycin therapy in oncology patients with fever and severe neutropenia.A potential role for daptomycin in enterococcal infections: what is the evidence?Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis.Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs PatientsDaptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry.Convergence of Minds: For Better Patient Outcome in Intensive Care Unit InfectionsIntrinsic and acquired resistance mechanisms in enterococcus.Emergence of clonal complex 17 Enterococcus faecium in The Netherlands.Daptomycin and tigecycline: a review of clinical efficacy in the antimicrobial era.Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents.Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.Antibiotic management of febrile neutropenia: current developments and future directions.Vancomycin-resistant enterococcal urinary tract infections.Management of gram-positive bacterial infections in patients with cancer.The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis.Antibiotic resistance in cancer patients.Vancomycin-resistant enterococcal bacteremia pharmacotherapy.Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.Therapeutic options for vancomycin-resistant enterococcal bacteremia.Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.A Novel Way of Treating Multidrug-resistant Enterococci.Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation.Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5 year comparison with conventional therapy.Daptomycin use in neutropenic patients with documented gram-positive infections.Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study designFailure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster.Daptomycin.
P2860
Q26851754-1C72B0E9-DB8E-4F7D-913E-ED52A0BDE4F4Q26853465-0CF51C3A-C926-4C7F-A677-18D663D460C9Q28302184-49796844-0C59-4B8F-AD5E-793F34205646Q33688646-EF44E978-7BE1-4C8A-9CCF-DE3A78403780Q33695234-2BC9B2AA-192D-4B5D-93EB-FC64F307AAA4Q33845776-3DE1F590-BBB2-47FC-BA61-D247EEF509D3Q34728711-09232F08-7152-412C-A7A6-2E01766BA9D9Q35999714-5C1F4164-11A1-41C4-BD44-B6547A896D83Q36059234-7F1F8C31-24CE-41AE-9A35-38FEB82DBF44Q36344076-9A5F239C-DF2F-4BF0-848A-1B48C12640A6Q36362547-9A37B5BB-3F04-4D45-BD0B-64272E037728Q36423673-329ABFF2-E748-4675-947C-2DB38DC53A5EQ36967265-F12DD83F-D476-4BA6-A94A-CC25AE08950CQ37377897-B34E7486-47B8-4943-83CB-79B18E11F10DQ37427850-1CE8F821-20E3-4C5F-85B7-27374EFA0963Q37532488-451875E4-6CD8-426B-8AF7-5676BE00F024Q37708866-A6FCD56C-3251-424E-AA56-9508BF36FE1CQ37802885-2A05ECCF-982C-4593-9A8F-A7B0480EB863Q37899198-82206596-767A-40F1-87B3-23773B66A1B0Q38125495-D6FCB845-5DE6-4A89-9087-AD0D29DF18F6Q38212258-64EAA17F-C893-4425-87FB-842816C17AC5Q38263421-CAD2CF74-45A5-4411-8948-CD2596DC42EDQ38325979-F17BF292-2BD1-4891-BFB2-4DADD5288F2AQ38347869-FFC6E81E-9CD5-47C2-805F-7134AC8C7CAEQ39910428-A9F1E519-5867-4994-B104-883DBBBCB9E1Q41696975-80CF7FD3-D634-4EC4-A159-88CE3CB2B7F4Q42064666-4B7D01BB-03F2-4C9B-97AF-84DAFCFE453AQ42189998-5FCDDB0C-AD3C-4188-A4BA-FDAE3B7CE0D0Q42202379-A3D22ECD-943C-42A4-A752-D7C42783A6E7Q42228134-66F2AF9F-6FBA-4231-ACDF-D60AE4E091FEQ42249906-EE25BFAC-E3C6-4640-AA4F-E966FA13C9BEQ42544277-B467DCEB-EFD9-4936-B9F5-3563E0F095FAQ46925072-98938713-CA44-4D5F-AA8D-F813923DCF74Q47616115-DB2CE32C-4217-4BD0-91E6-10836C84AEEA
P2860
Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Daptomycin in the treatment of ...... remia in neutropenic patients.
@ast
Daptomycin in the treatment of ...... remia in neutropenic patients.
@en
type
label
Daptomycin in the treatment of ...... remia in neutropenic patients.
@ast
Daptomycin in the treatment of ...... remia in neutropenic patients.
@en
prefLabel
Daptomycin in the treatment of ...... remia in neutropenic patients.
@ast
Daptomycin in the treatment of ...... remia in neutropenic patients.
@en
P2093
P2860
P1433
P1476
Daptomycin in the treatment of ...... eremia in neutropenic patients
@en
P2093
Debra D Poutsiaka
Kenneth B Miller
Serena Skiffington
Susan Hadley
P2860
P304
P356
10.1016/J.JINF.2006.11.007
P577
2006-12-26T00:00:00Z